HDII (Hypertension Diagnostics) Shares Buyback Ratio %: 0.00 (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypertension Diagnostics Shares Buyback Ratio %?

Hypertension Diagnostics HDII -99.00% Shares Buyback Ratio % is 0.00 as of Jul. 25, 2026.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Hypertension Diagnostics's current shares buyback ratio was 0.00%.

Hypertension Diagnostics Shares Buyback Ratio % Related Terms

Hypertension Diagnostics Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Shares Buyback Ratio % Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.36 -20.92 0.00 0.00 0.00

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hypertension Diagnostics Shares Buyback Ratio % Calculation

Hypertension Diagnostics's Shares Buyback Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2017 ) - Shares Outstanding (EOP) (A: Dec. 2018 )) / Shares Outstanding (EOP) (A: Dec. 2017 )
=(52.389 - 52.389) / 52.389
=0.00%

Hypertension Diagnostics's Shares Buyback Ratio for the quarter that ended in Sep. 2019 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2019 ) - Shares Outstanding (EOP) (A: Sep. 2019 )) / Shares Outstanding (EOP) (A: Jun. 2019 )
=(52.389 - 52.389) / 52.389
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of 0.00 mean?
Hypertension Diagnostics (HDII) has a Shares Buyback Ratio % of 0.00 as of Jul. 25, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Hypertension Diagnostics and its competitors.
Is Hypertension Diagnostics' Shares Buyback Ratio % too high?
Hypertension Diagnostics' current Shares Buyback Ratio % is 0.00.
How does Hypertension Diagnostics' Shares Buyback Ratio % compare to ESTRF and OCLN?
Hypertension Diagnostics' Shares Buyback Ratio % of 0.00 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Diversified Financial Services company?
A good Shares Buyback Ratio % depends on the Diversified Financial Services industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on Hypertension Diagnostics and its competitors. Hypertension Diagnostics's current Shares Buyback Ratio % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current Shares Buyback Ratio % of 0.00. The current Shares Buyback Ratio % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current Shares Buyback Ratio % is 0.00 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.